Associated Papers
Mutations in multiple domains of Gag drive the emergence of in vitro resistance to the phosphonate-containing HIV-1 protease inhibitor GS-8374.
Stray KM et al.
Journal of Virology, 2013
Drug resistance during indinavir therapy is caused by mutations in the protease gene and in its Gag substrate cleavage sites.
Zhang YM et al.
Journal of Virology, 1997
A mutation in human immunodeficiency virus type 1 protease at position 88, located outside the active site, confers resistance to the hydroxyethylurea inhibitor SC-55389A.
Smidt ML et al.
Antimicrobial Agents and Chemotherapy, 1997
Select a paper to view details